120 related articles for article (PubMed ID: 321174)
1. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of clonidine in tetraplegic subjects devoid of central sympathetic control.
Mathias CJ; Reid JL; Wing LM; Frankel HL; Christensen NJ
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():425s-428s. PubMed ID: 540463
[TBL] [Abstract][Full Text] [Related]
5. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
Findlay D; Lawrence JR
Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology and pharmacokinetics of clonidine.
Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions. Evidence for a central sympatholytic action.
Kooner JS; Birch R; Frankel HL; Peart WS; Mathias CJ
Circulation; 1991 Jul; 84(1):75-83. PubMed ID: 2060125
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine.
Davies DS; Wing AM; Reid JL; Neill DM; Tippett P; Dollery CT
Clin Pharmacol Ther; 1977 May; 21(5):593-601. PubMed ID: 870272
[TBL] [Abstract][Full Text] [Related]
10. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
Sala P; Chierichetti SM; Ferrari P
Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
[TBL] [Abstract][Full Text] [Related]
11. Sedative and cardiovascular effects of clonidine and nitrazepam.
Hossmann V; Maling TJ; Hamilton CA; Reid JL; Dollery CT
Clin Pharmacol Ther; 1980 Aug; 28(2):167-76. PubMed ID: 7398184
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic and pharmacodynamic studies of oral clonidine in normotensive subjects.
Anavekar SN; Jarrott B; Toscano M; Louis WJ
Eur J Clin Pharmacol; 1982; 23(1):1-5. PubMed ID: 7128667
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cardiovascular effects of clonidine in conscious and anesthetized rabbits.
Tangri KK; Petty M; Wing LM; Reid JL
J Pharmacol Exp Ther; 1977 Jul; 202(1):69-75. PubMed ID: 195037
[TBL] [Abstract][Full Text] [Related]
14. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and side-effects of clonidine.
Keränen A; Nykänen S; Taskinen J
Eur J Clin Pharmacol; 1978 May; 13(2):97-101. PubMed ID: 658114
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the effect of azepexole and clonidine on blood pressure and pulse rate in normotensive subjects.
Benedikter L; Mey T; Middleton DA
Eur J Clin Pharmacol; 1981; 20(5):321-8. PubMed ID: 7026259
[TBL] [Abstract][Full Text] [Related]
18. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
Veith RC; Best JD; Halter JB
J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
[TBL] [Abstract][Full Text] [Related]
19. Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit.
Dollery CT; Reid JL
Br J Pharmacol; 1973 Feb; 47(2):206-16. PubMed ID: 4722037
[TBL] [Abstract][Full Text] [Related]
20. Relationship of plasma clonidine to growth hormone concentrations in children and adolescents.
Hoffman WH; DiPiro JT; Tackett RL; Arrendale RF; Hahn DA
J Clin Pharmacol; 1989 Jun; 29(6):538-42. PubMed ID: 2754022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
